Global Home Blood Testing Devices Market 2024-2028
Global Home Blood Testing Devices Market 2024-2028
The home blood testing devices market is forecasted to grow by USD 2959.1 mn during 2023-2028, accelerating at a CAGR of 4.66% during the forecast period. The report on the home blood testing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing contagious disease outbreaks, growing demand for convenient blood testing solutions, and rising prevalence of chronic diseases.
Technavio's home blood testing devices market is segmented as below:
By Distribution Channel
- Hospital pharmacies
- Online
- Drug stores
By Product Type
- Glucose monitors
- Cholestrol kits
- Coagulation test kits
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the technological advancements in home blood testing devices as one of the prime reasons driving the home blood testing devices market growth during the next few years. Also, integration of data analytics in home blood testing devices and innovative marketing strategies adapted by vendors will lead to sizable demand in the market.
The report on the home blood testing devices market covers the following areas:
- Home blood testing devices market sizing
- Home blood testing devices market forecast
- Home blood testing devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading home blood testing devices market vendors that include A and D HOLON Holdings Co. Ltd., Abbott Laboratories, ARKRAY Inc., Becton Dickinson and Co., Beurer India Pvt. Ltd., Bio Rad Laboratories Inc., BioMerieux SA, Bionime Corp., Danaher Corp., F. Hoffmann La Roche Ltd., i-SENS, Inc., LifeScan IP Holdings LLC, Medaval Ltd, Microgene Diagnostic Systems Pvt. Ltd., Minaris Medical America, Inc., Nova Biomedical Corp., PixCell Medical Technologies Ltd., Thermo Fisher Scientific Inc., Trajan Scientific Australia Pty Ltd., and Truvian Sciences Inc.. Also, the home blood testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.